Insider filing · MRNA
Stephane Bancel
Chief Executive Officer
profile →
Moderna, Inc.
MRNA · Healthcare · 20 filings in 24 months
ticker →
Stephane Bancel sold $28.7M of Moderna (MRNA)
Executed Aug 5, disclosed Aug 7, 2 days later.
Value, as filed
$28.7M
499,246 sh across 4 lots
Executed
Aug 5
the trade date, as filed
Disclosed
Aug 7
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBStephane Bancel (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Moderna, Inc. (MRNA). The largest single filing was $28.7M of MRNA (499,246 sh across 4 lots, as filed), executed Aug 5.
The name
MRNAHealthcare · Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephane Bancel in MRNA
MRNAPURCHASE
Moderna, Inc.
$5.0M160,314 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET